Atezolizumab,Bevacizumab
roche
['genentech']
#breaking: today at #aacr23, we shared new phase iii data evaluating our cancer immunotherapy combination for people with certain types of liver cancer. learn more: 
Official Twitter for Genentech. See our community guidelines here: https://t.co/yas51FPhKU